Show simple item record

dc.contributor.authorHansen, Carsten Gram*
dc.date.accessioned2021-02-11T11:33:51Z
dc.date.available2021-02-11T11:33:51Z
dc.date.issued2019*
dc.date.submitted2019-12-09 11:49:16*
dc.identifier42670*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/45263
dc.description.abstractThe Hippo pathway is a highly dynamic cellular signaling nexus that plays central roles in multiple cell types and regulates regeneration, metabolism, and development. The Hippo pathway integrates mechanotransduction, cell polarity, inflammation, and numerous types of paracrine signaling. If not tightly regulated, dysregulated Hippo pathway signaling drives the onset and progression of a range of diseases, including fibrosis and cancer. The molecular understanding of the Hippo pathway is rapidly evolving. This Special Issue contains ten articles contributed by established and up-and-coming Hippo pathway experts that, as a whole, provides an up-to-date overview of how dysregulated Hippo pathway activity is a common driver of specific diseases. The articles have a particular focus on the underlying molecular and cellular mechanisms that cause the Hippo pathway to go awry, and especially how this drives disease. The articles analyze disease-specific as well as common themes, which provides valuable insights into the fundamental molecular mechanisms in the dysfunctioning Hippo pathway, and thereby offer practical insights into potential future therapeutic intervention strategies.*
dc.languageEnglish*
dc.subjectQH301-705.5*
dc.subjectQ1-390*
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.otherSTRIPAK*
dc.subject.otherskin cancer*
dc.subject.othern/a*
dc.subject.otherLats2*
dc.subject.othertranscription*
dc.subject.othermyofibroblast*
dc.subject.otherepigenetic*
dc.subject.otherHippo*
dc.subject.othercancer immunity*
dc.subject.otherTAZ*
dc.subject.otherTaz*
dc.subject.otherTAZ (transcriptional co-activator with PDZ-binding motif)*
dc.subject.otheradaptive immunity*
dc.subject.otherfibroblasts*
dc.subject.otherinnate immunity*
dc.subject.otherLATS*
dc.subject.otherMST (mammalian STE20-like protein kinase)*
dc.subject.otherphosphorylation*
dc.subject.otherstem cells*
dc.subject.otherwound healing*
dc.subject.othersignal transduction*
dc.subject.otherangiogenesis*
dc.subject.otherLATS1/2*
dc.subject.otherEMT*
dc.subject.otherprotein-protein interactions*
dc.subject.otherstructure biology*
dc.subject.otherHippo pathway*
dc.subject.otherhippo pathway*
dc.subject.otherautoimmunity*
dc.subject.otherMps one binder*
dc.subject.otherYAP/TAZ*
dc.subject.otherGPCR*
dc.subject.otherfibrosis*
dc.subject.otherMST1/2*
dc.subject.otherYAP (yes-associated protein)*
dc.subject.otherYAP*
dc.subject.otherYap*
dc.subject.otherprotein kinase*
dc.subject.otherLATS (large tumor suppressor kinase)*
dc.subject.otherperipheral nerve sheath tumor*
dc.subject.othersignal cross-talk*
dc.subject.otherstem cell*
dc.subject.otherskin development*
dc.subject.otherSTK38*
dc.subject.othertumorigenesis*
dc.subject.otherNDR*
dc.subject.otherschwannoma*
dc.subject.otherG protein-coupled receptor*
dc.subject.otheranti-cancer therapy*
dc.subject.otherfeedback loops*
dc.subject.othervascular mimicry*
dc.subject.othercastration resistance*
dc.subject.otherchromatin*
dc.subject.otherHippo signalling*
dc.subject.otherECM*
dc.subject.otherMST*
dc.subject.otherprostate cancer*
dc.subject.otherTEAD*
dc.subject.othercancer*
dc.subject.otherzebrafish*
dc.titleDisease and the Hippo Pathway: Cellular and Molecular Mechanisms*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-777-9*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039217762*
oapen.relation.isbn9783039217779*
oapen.pages226*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/